NCT02940561 - BE Study in Patients - Methotrexate Tablets | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

PsoriasisRheumatoid Arthritis

Interventions

DRUG

Methotrexate - Amneal

"Methotrexate Tablets, USP contain an amount of methotrexate sodium equivalent to 2.5 mg of methotrexate, USP and are round, biconvex, yellow tablets, scored in half on one side, engraved with A above the score and 1 below"

DRUG

Methotrexate - DAVA

Methotrexate Tablets, USP contain an amount of methotrexate sodium equivalent to 2.5 mg of methotrexate and are round, convex, yellow tablets, scored in half on one side, engraved with M above the score, and 1 below

Trial Locations (3)

380009

RECRUITING

Saviour Hospital, Ahmedabad

380052

RECRUITING

Sterling Hospital, Ahmedabad

382428

RECRUITING

Kanoria Hospital, Gandhinagar